Rheumatology diseases affects the supporting or connecting structures of the body mostly joints, ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized by inflammation of joints and it affects spine in some types of rheumatology disease. There are more than 100 types of rheumatic disease. It is caused by various genetic and environmental factors, such as unhealthy diet and changing lifestyle, which can lead to rheumatology diseases. Osteoarthritis, ankylosing spondylitis, rheumatoid arthritis, gout, psoriatic arthritis, reactive arthritis, fibromyalgia, and scleroderma are some of the common types of rheumatology diseases. Arthritis is a complex disease that affects the bones and joints of the body causing inflammation and pain. When people have this disease, they have to face difficulties in their day to day life because it affects their mobility as well as their ability to do their daily chores. Osteoarthritis is one of the most common types of arthritis and it usually affects the elderly. Osteoarthritis can cause swelling, joint pains, and even deformity especially when the bones begin to break.
Request Here For FREE PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/796
The symptoms of osteoarthritis include pain and swelling of the affected area which can be located anywhere from the spine down to the hips. Osteoarthritis is believed to be hereditary and people inherit an increased risk of developing osteoarthritis, not the condition itself. Rheumatology diseases are complex and they involve a lot of factors which includes lifestyle, genetics, immune system, and the environment.
Recent Developments
Major players operating in the global rheumatology therapeutics market are focused on approval and launch of new drugs to expand their product portfolio. For instance, in 2020, Sandoz Canada Inc., a generics and biosimilars manufacturer and a division of the Switzerland-based multinational Novartis AG, received Health Canada authorization for Hyrimoz for the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, psoriasis and adult uveitis.
Global Rheumatology Therapeutics Market: Drivers
High prevalence of rheumatology diseases is expected to propel growth of the global rheumatology therapeutics market over the forecast period. For instance, according to the study, ‘Osteoarthritis year in review 2019: epidemiology and therapy’, published in the journal Osteoarthritis and Cartilage in January 2020, the median proportion of years lived with disability due to musculoskeletal disorders increased from 11.8% in 2000 to 13.5% (9.6–16.6) in 2015.
Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to The United Nations Economic and Social Commission for Asia and the Pacific, over a third of the population in Asia Pacific is expected to be 60 years or older by 2050.
Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/796
Market Trends
Europe is expected to witness significant growth in the global rheumatology therapeutics market, owing to high prevalence of osteoarthritis in the region. For instance, according to the study ‘Osteoarthritis in Europe: Impact on health status, work productivity and use of pharmacotherapies in five European countries’ that examined the impact of peripheral joint osteoarthritis across five European countries, UK (43.6%), France, (25.6%), Germany, (15.2%), Spain, (8.4%), and Italy (7.1%) recorded high prevalence of peripheral joint osteoarthritis, with majority of cases aging 55-74 years.
Global Rheumatology Therapeutics Market: Competitive Landscape
Major players operating in the global rheumatology therapeutics market include, Alder Biopharmaceuticals, AstraZeneca, Abbott Laboratories, Amgen, Eli Lily, and Company, Janssen Biotech, Merck Co. Inc., Pfizer, and Rigel Pharma.
Global Rheumatology Therapeutics Market: Key Developments
Major players operating in the global rheumatology therapeutics market are focused on adopting partnership strategies to expand their product portfolio. For instance, in 2009, Bristol-Myers Squibb Company partnered with Alder Biopharmaceuticals, Inc. for the development and commercialization of ALD518, a novel biologic for the treatment of rheumatoid arthritis.
Major players operating in the global rheumatology therapeutics market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in June 2012, AstraZeneca acquired Ardea Biosciences, Inc.
Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/796
Global Rheumatology Therapeutics Market: Segmentation
By Disease Type
- Osteoarthritis
- Ankylosing spondylitis
- Rheumatoid arthritis
- Gout
- Psoriatic arthritis
- Reactive arthritis
- Fibromyalgia
- Scleroderma
- Others
By Drug Type
- Disease Modifying Antirheumatic Drugs (DMADs)
- Humira
- Remicade
- Cyclosporine
- Methotrexate
- Biologics
- Tofacitinib
- Others
By End User
- Hospitals
- Medical clinics
Reasons to Purchase this Report
• Current and future of global Rheumatology Therapeutics Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/796
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Rheumatology Therapeutics Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Rheumatology Therapeutics Industry Impact
Chapter 2 Global Rheumatology Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Rheumatology Therapeutics (Volume and Value) by Type
2.3 Global Rheumatology Therapeutics (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Rheumatology Therapeutics Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Rheumatology Therapeutics Market Analysis
Chapter 6 East Asia Rheumatology Therapeutics Market Analysis
Chapter 7 Europe Rheumatology Therapeutics Market Analysis
Chapter 8 South Asia Rheumatology Therapeutics Market Analysis
Chapter 9 Southeast Asia Rheumatology Therapeutics Market Analysis
Chapter 10 Middle East Rheumatology Therapeutics Market Analysis
Chapter 11 Africa Rheumatology Therapeutics Market Analysis
Chapter 12 Oceania Rheumatology Therapeutics Market Analysis
Chapter 13 South America Rheumatology Therapeutics Market Analysis
Chapter 14 Company Profiles and Key Figures in Rheumatology Therapeutics Business
Chapter 15 Global Rheumatology Therapeutics Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837